Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms

Identifieur interne : 000283 ( PascalFrancis/Corpus ); précédent : 000282; suivant : 000284

Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms

Auteurs : Mei Rosemary Fu ; Mary Rosedale

Source :

RBID : Pascal:10-0073697

Descripteurs français

English descriptors

Abstract

Context. As a serious chronic condition from breast cancer treatment, lymphedema or a syndrome of persistent swelling and symptoms is caused by chronic accumulation of lymph fluid in the interstitial spaces of the affected limb or surrounding areas. Although significant prevalence of ongoing multiple symptoms has been reported, little is known about how survivors with lymphedema perceive and respond to lymphedema-related symptoms in their daily lives. Objectives. The purpose of this study was to explore and describe breast cancer survivors' lymphedema-related symptom experiences. Methods. This study used a descriptive phenomenological method. Thirty-four participants were recruited in the United States. Three in-depth interviews were conducted with each participant; a total of 102 interviews were completed, audio taped, and transcribed. Interview transcripts and field notes were the data sources for this analysis, which was part of three larger studies. Data were analyzed to identify the essential themes within and across cases. Results. Four essential themes were revealed: living with perpetual discomfort, confronting the unexpected, losing pre-lymphedema being, and feeling handicapped. Participants experienced multiple symptoms on a daily basis. Distress was heightened when women expected symptoms to disappear, but instead, they remained as a "perpetual discomfort." Moreover, distress was intensified when symptoms evoked unexpected situations or when symptoms elicited emotional responses powerful enough to change perceived personal identity. Conclusions. Findings suggest that symptom distress may encompass temporal, situational, and attributive dimensions. Prospective studies are needed to examine lymphedema-related symptom distress in terms of these dimensions so that more specific interventions can be developed to target distress occurring in each dimension.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3924
A03   1    @0 J. pain symptom manage.
A05       @2 38
A06       @2 6
A08 01  1  ENG  @1 Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms
A11 01  1    @1 FU (Mei Rosemary)
A11 02  1    @1 ROSEDALE (Mary)
A14 01      @1 New York University College of Nursing @2 New York, New York @3 USA @Z 1 aut. @Z 2 aut.
A20       @1 849-859
A21       @1 2009
A23 01      @0 ENG
A43 01      @1 INIST @2 21986 @5 354000189988990050
A44       @0 0000 @1 © 2010 INIST-CNRS. All rights reserved.
A45       @0 25 ref.
A47 01  1    @0 10-0073697
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of pain and symptom management
A66 01      @0 USA
C01 01    ENG  @0 Context. As a serious chronic condition from breast cancer treatment, lymphedema or a syndrome of persistent swelling and symptoms is caused by chronic accumulation of lymph fluid in the interstitial spaces of the affected limb or surrounding areas. Although significant prevalence of ongoing multiple symptoms has been reported, little is known about how survivors with lymphedema perceive and respond to lymphedema-related symptoms in their daily lives. Objectives. The purpose of this study was to explore and describe breast cancer survivors' lymphedema-related symptom experiences. Methods. This study used a descriptive phenomenological method. Thirty-four participants were recruited in the United States. Three in-depth interviews were conducted with each participant; a total of 102 interviews were completed, audio taped, and transcribed. Interview transcripts and field notes were the data sources for this analysis, which was part of three larger studies. Data were analyzed to identify the essential themes within and across cases. Results. Four essential themes were revealed: living with perpetual discomfort, confronting the unexpected, losing pre-lymphedema being, and feeling handicapped. Participants experienced multiple symptoms on a daily basis. Distress was heightened when women expected symptoms to disappear, but instead, they remained as a "perpetual discomfort." Moreover, distress was intensified when symptoms evoked unexpected situations or when symptoms elicited emotional responses powerful enough to change perceived personal identity. Conclusions. Findings suggest that symptom distress may encompass temporal, situational, and attributive dimensions. Prospective studies are needed to examine lymphedema-related symptom distress in terms of these dimensions so that more specific interventions can be developed to target distress occurring in each dimension.
C02 01  X    @0 002B02
C02 02  X    @0 002B20E02
C02 03  X    @0 002B12B04
C03 01  X  FRE  @0 Cancer du sein @2 NM @5 01
C03 01  X  ENG  @0 Breast cancer @2 NM @5 01
C03 01  X  SPA  @0 Cáncer del pecho @2 NM @5 01
C03 02  X  FRE  @0 Homme @5 02
C03 02  X  ENG  @0 Human @5 02
C03 02  X  SPA  @0 Hombre @5 02
C03 03  X  FRE  @0 Survivant @5 03
C03 03  X  ENG  @0 Survivor @5 03
C03 03  X  SPA  @0 Sobreviviente @5 03
C03 04  X  FRE  @0 Lymphoedème @5 04
C03 04  X  ENG  @0 Lymphedema @5 04
C03 04  X  SPA  @0 Linfedema @5 04
C03 05  X  FRE  @0 Symptomatologie @5 05
C03 05  X  ENG  @0 Symptomatology @5 05
C03 05  X  SPA  @0 Sintomatología @5 05
C07 01  X  FRE  @0 Tumeur maligne @2 NM @5 37
C07 01  X  ENG  @0 Malignant tumor @2 NM @5 37
C07 01  X  SPA  @0 Tumor maligno @2 NM @5 37
C07 02  X  FRE  @0 Cancer @2 NM
C07 02  X  ENG  @0 Cancer @2 NM
C07 02  X  SPA  @0 Cáncer @2 NM
C07 03  X  FRE  @0 Pathologie de la glande mammaire @2 NM @5 38
C07 03  X  ENG  @0 Mammary gland diseases @2 NM @5 38
C07 03  X  SPA  @0 Glándula mamaria patología @2 NM @5 38
C07 04  X  FRE  @0 Pathologie du sein @2 NM @5 39
C07 04  X  ENG  @0 Breast disease @2 NM @5 39
C07 04  X  SPA  @0 Seno patología @2 NM @5 39
C07 05  X  FRE  @0 Pathologie de l'appareil circulatoire @5 40
C07 05  X  ENG  @0 Cardiovascular disease @5 40
C07 05  X  SPA  @0 Aparato circulatorio patología @5 40
C07 06  X  FRE  @0 Pathologie des vaisseaux lymphatiques @5 41
C07 06  X  ENG  @0 Lymphatic vessel disease @5 41
C07 06  X  SPA  @0 Linfático patología @5 41
N21       @1 046
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 10-0073697 INIST
ET : Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms
AU : FU (Mei Rosemary); ROSEDALE (Mary)
AF : New York University College of Nursing/New York, New York/Etats-Unis (1 aut., 2 aut.)
DT : Publication en série; Niveau analytique
SO : Journal of pain and symptom management; ISSN 0885-3924; Etats-Unis; Da. 2009; Vol. 38; No. 6; Pp. 849-859; Bibl. 25 ref.
LA : Anglais
EA : Context. As a serious chronic condition from breast cancer treatment, lymphedema or a syndrome of persistent swelling and symptoms is caused by chronic accumulation of lymph fluid in the interstitial spaces of the affected limb or surrounding areas. Although significant prevalence of ongoing multiple symptoms has been reported, little is known about how survivors with lymphedema perceive and respond to lymphedema-related symptoms in their daily lives. Objectives. The purpose of this study was to explore and describe breast cancer survivors' lymphedema-related symptom experiences. Methods. This study used a descriptive phenomenological method. Thirty-four participants were recruited in the United States. Three in-depth interviews were conducted with each participant; a total of 102 interviews were completed, audio taped, and transcribed. Interview transcripts and field notes were the data sources for this analysis, which was part of three larger studies. Data were analyzed to identify the essential themes within and across cases. Results. Four essential themes were revealed: living with perpetual discomfort, confronting the unexpected, losing pre-lymphedema being, and feeling handicapped. Participants experienced multiple symptoms on a daily basis. Distress was heightened when women expected symptoms to disappear, but instead, they remained as a "perpetual discomfort." Moreover, distress was intensified when symptoms evoked unexpected situations or when symptoms elicited emotional responses powerful enough to change perceived personal identity. Conclusions. Findings suggest that symptom distress may encompass temporal, situational, and attributive dimensions. Prospective studies are needed to examine lymphedema-related symptom distress in terms of these dimensions so that more specific interventions can be developed to target distress occurring in each dimension.
CC : 002B02; 002B20E02; 002B12B04
FD : Cancer du sein; Homme; Survivant; Lymphoedème; Symptomatologie
FG : Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein; Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques
ED : Breast cancer; Human; Survivor; Lymphedema; Symptomatology
EG : Malignant tumor; Cancer; Mammary gland diseases; Breast disease; Cardiovascular disease; Lymphatic vessel disease
SD : Cáncer del pecho; Hombre; Sobreviviente; Linfedema; Sintomatología
LO : INIST-21986.354000189988990050
ID : 10-0073697

Links to Exploration step

Pascal:10-0073697

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms</title>
<author>
<name sortKey="Fu, Mei Rosemary" sort="Fu, Mei Rosemary" uniqKey="Fu M" first="Mei Rosemary" last="Fu">Mei Rosemary Fu</name>
<affiliation>
<inist:fA14 i1="01">
<s1>New York University College of Nursing</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rosedale, Mary" sort="Rosedale, Mary" uniqKey="Rosedale M" first="Mary" last="Rosedale">Mary Rosedale</name>
<affiliation>
<inist:fA14 i1="01">
<s1>New York University College of Nursing</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">10-0073697</idno>
<date when="2009">2009</date>
<idno type="stanalyst">PASCAL 10-0073697 INIST</idno>
<idno type="RBID">Pascal:10-0073697</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000283</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms</title>
<author>
<name sortKey="Fu, Mei Rosemary" sort="Fu, Mei Rosemary" uniqKey="Fu M" first="Mei Rosemary" last="Fu">Mei Rosemary Fu</name>
<affiliation>
<inist:fA14 i1="01">
<s1>New York University College of Nursing</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rosedale, Mary" sort="Rosedale, Mary" uniqKey="Rosedale M" first="Mary" last="Rosedale">Mary Rosedale</name>
<affiliation>
<inist:fA14 i1="01">
<s1>New York University College of Nursing</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of pain and symptom management</title>
<title level="j" type="abbreviated">J. pain symptom manage.</title>
<idno type="ISSN">0885-3924</idno>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of pain and symptom management</title>
<title level="j" type="abbreviated">J. pain symptom manage.</title>
<idno type="ISSN">0885-3924</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Breast cancer</term>
<term>Human</term>
<term>Lymphedema</term>
<term>Survivor</term>
<term>Symptomatology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Cancer du sein</term>
<term>Homme</term>
<term>Survivant</term>
<term>Lymphoedème</term>
<term>Symptomatologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Context. As a serious chronic condition from breast cancer treatment, lymphedema or a syndrome of persistent swelling and symptoms is caused by chronic accumulation of lymph fluid in the interstitial spaces of the affected limb or surrounding areas. Although significant prevalence of ongoing multiple symptoms has been reported, little is known about how survivors with lymphedema perceive and respond to lymphedema-related symptoms in their daily lives. Objectives. The purpose of this study was to explore and describe breast cancer survivors' lymphedema-related symptom experiences. Methods. This study used a descriptive phenomenological method. Thirty-four participants were recruited in the United States. Three in-depth interviews were conducted with each participant; a total of 102 interviews were completed, audio taped, and transcribed. Interview transcripts and field notes were the data sources for this analysis, which was part of three larger studies. Data were analyzed to identify the essential themes within and across cases. Results. Four essential themes were revealed: living with perpetual discomfort, confronting the unexpected, losing pre-lymphedema being, and feeling handicapped. Participants experienced multiple symptoms on a daily basis. Distress was heightened when women expected symptoms to disappear, but instead, they remained as a "perpetual discomfort." Moreover, distress was intensified when symptoms evoked unexpected situations or when symptoms elicited emotional responses powerful enough to change perceived personal identity. Conclusions. Findings suggest that symptom distress may encompass temporal, situational, and attributive dimensions. Prospective studies are needed to examine lymphedema-related symptom distress in terms of these dimensions so that more specific interventions can be developed to target distress occurring in each dimension.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3924</s0>
</fA01>
<fA03 i2="1">
<s0>J. pain symptom manage.</s0>
</fA03>
<fA05>
<s2>38</s2>
</fA05>
<fA06>
<s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>FU (Mei Rosemary)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>ROSEDALE (Mary)</s1>
</fA11>
<fA14 i1="01">
<s1>New York University College of Nursing</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>849-859</s1>
</fA20>
<fA21>
<s1>2009</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>21986</s2>
<s5>354000189988990050</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>25 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>10-0073697</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of pain and symptom management</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Context. As a serious chronic condition from breast cancer treatment, lymphedema or a syndrome of persistent swelling and symptoms is caused by chronic accumulation of lymph fluid in the interstitial spaces of the affected limb or surrounding areas. Although significant prevalence of ongoing multiple symptoms has been reported, little is known about how survivors with lymphedema perceive and respond to lymphedema-related symptoms in their daily lives. Objectives. The purpose of this study was to explore and describe breast cancer survivors' lymphedema-related symptom experiences. Methods. This study used a descriptive phenomenological method. Thirty-four participants were recruited in the United States. Three in-depth interviews were conducted with each participant; a total of 102 interviews were completed, audio taped, and transcribed. Interview transcripts and field notes were the data sources for this analysis, which was part of three larger studies. Data were analyzed to identify the essential themes within and across cases. Results. Four essential themes were revealed: living with perpetual discomfort, confronting the unexpected, losing pre-lymphedema being, and feeling handicapped. Participants experienced multiple symptoms on a daily basis. Distress was heightened when women expected symptoms to disappear, but instead, they remained as a "perpetual discomfort." Moreover, distress was intensified when symptoms evoked unexpected situations or when symptoms elicited emotional responses powerful enough to change perceived personal identity. Conclusions. Findings suggest that symptom distress may encompass temporal, situational, and attributive dimensions. Prospective studies are needed to examine lymphedema-related symptom distress in terms of these dimensions so that more specific interventions can be developed to target distress occurring in each dimension.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B02</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B20E02</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Breast cancer</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Homme</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Human</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Survivant</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Survivor</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Sobreviviente</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Symptomatologie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Symptomatology</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Sintomatología</s0>
<s5>05</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Breast disease</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Seno patología</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie de l'appareil circulatoire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>046</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 10-0073697 INIST</NO>
<ET>Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms</ET>
<AU>FU (Mei Rosemary); ROSEDALE (Mary)</AU>
<AF>New York University College of Nursing/New York, New York/Etats-Unis (1 aut., 2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of pain and symptom management; ISSN 0885-3924; Etats-Unis; Da. 2009; Vol. 38; No. 6; Pp. 849-859; Bibl. 25 ref.</SO>
<LA>Anglais</LA>
<EA>Context. As a serious chronic condition from breast cancer treatment, lymphedema or a syndrome of persistent swelling and symptoms is caused by chronic accumulation of lymph fluid in the interstitial spaces of the affected limb or surrounding areas. Although significant prevalence of ongoing multiple symptoms has been reported, little is known about how survivors with lymphedema perceive and respond to lymphedema-related symptoms in their daily lives. Objectives. The purpose of this study was to explore and describe breast cancer survivors' lymphedema-related symptom experiences. Methods. This study used a descriptive phenomenological method. Thirty-four participants were recruited in the United States. Three in-depth interviews were conducted with each participant; a total of 102 interviews were completed, audio taped, and transcribed. Interview transcripts and field notes were the data sources for this analysis, which was part of three larger studies. Data were analyzed to identify the essential themes within and across cases. Results. Four essential themes were revealed: living with perpetual discomfort, confronting the unexpected, losing pre-lymphedema being, and feeling handicapped. Participants experienced multiple symptoms on a daily basis. Distress was heightened when women expected symptoms to disappear, but instead, they remained as a "perpetual discomfort." Moreover, distress was intensified when symptoms evoked unexpected situations or when symptoms elicited emotional responses powerful enough to change perceived personal identity. Conclusions. Findings suggest that symptom distress may encompass temporal, situational, and attributive dimensions. Prospective studies are needed to examine lymphedema-related symptom distress in terms of these dimensions so that more specific interventions can be developed to target distress occurring in each dimension.</EA>
<CC>002B02; 002B20E02; 002B12B04</CC>
<FD>Cancer du sein; Homme; Survivant; Lymphoedème; Symptomatologie</FD>
<FG>Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein; Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques</FG>
<ED>Breast cancer; Human; Survivor; Lymphedema; Symptomatology</ED>
<EG>Malignant tumor; Cancer; Mammary gland diseases; Breast disease; Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Cáncer del pecho; Hombre; Sobreviviente; Linfedema; Sintomatología</SD>
<LO>INIST-21986.354000189988990050</LO>
<ID>10-0073697</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000283 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000283 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:10-0073697
   |texte=   Breast Cancer Survivors' Experiences of Lymphedema-Related Symptoms
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024